SAU:4013
Dr. Sulaiman Al Habib Medical Services Group Company · SAU · Healthcare · SAR · FY for 2025
Figures on this page computed 2026-11-08 04:11 UTC
Last close
n/aSAR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
31.5xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
- Computed from the filing for 2025
17.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
17.5%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.18Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.2%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
Price is the furthest below its sector's middle: 0.20 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.84x
Its own average over 10 years, 7.47B.
- Profit1.69x
Its own average over 10 years, 1.42B.
- Free cash flow0.26x
Its own average over 10 years, 386.9M.
- Debt2.44x
Its own average over 10 years, 3.82B.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 2.44 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 90.0 | 65.0 | 100.0 |
| 2018-12-31 | 94.2 | 79.3 | 100.0 |
| 2019-12-31 | 103.0 | 86.2 | 100.0 |
| 2020-12-31 | 120.4 | 104.5 | 100.0 |
| 2021-12-31 | 148.9 | 136.3 | 100.0 |
| 2022-12-31 | 170.7 | 163.5 | 100.0 |
| 2023-12-31 | 195.3 | 202.6 | 100.0 |
| 2024-12-31 | 230.1 | 229.3 | 100.0 |
| 2025-12-31 | 281.6 | 237.8 | 100.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Figures behind the shape
Growth
18.5%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate18.5%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
Five-year EPS growth rate17.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
One-year change in net income3.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
Returns on capital
17.5%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital17.5%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity30.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets10.3%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
30.7%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin30.7%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin19.3%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin17.5%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin0.7%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
31.5xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings31.5x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
- Computed from the filing for 2025
Price to book9.6x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA24.9x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio5.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.18safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity1.18
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.15
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage7.3x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score4.33
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
2.2%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield2.2%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
Payout ratio69.2%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio0.1x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SAR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.